Tech Company Financing Transactions
TissueTech Funding Round
Ballast Point Ventures and River Cities Capital Funds participated in a $10 million capital raise for TissueTech. The financing round was announced on 8/23/2013.
Transaction Overview
Company Name
Announced On
8/23/2013
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Ballast Point Ventures (Matthew Rice)
River Cities Capital Funds (Carter McNabb)
Proceeds Purpose
The funding will be largely used to accelerate commercial efforts and further research and development in both divisions.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7300 Corporate Center Dr. 700
Miami, FL 33126
USA
Miami, FL 33126
USA
Phone
Website
Email Address
Overview
Our mission is to develop and deliver high-quality and innovative regenerative wound healing solutions to eyecare providers and their patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amy Tseng
Chief Financial Officer
Michael Cornelius
Chief Scientific Officer
Scheffer Tseng
VP - General Counsel
Devin Buckley
VP - Operations
Alan Petro
VP - Regulatory Affairs
Frank Young
Browse more venture capital transactions:
Prev: 8/23/2013: SkyFuel venture capital transaction
Next: 8/24/2013: Gratafy venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs